Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort.

doi:10.1158/1055-9965.EPI-08-0044

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Jul 2008

Mucci Lorelei A, Pawitan Yudi, Demichelis Francesca, Fall Katja, Stark Jennifer R, Adami Hans-Olov, Andersson Swen-Olof, Andrén Ove, Eisenstein Anna, Holmberg Lars, Huang Wei, Kantoff Philip W, Kim Robert, Perner Sven, Stampfer Meir J, Johansson Jan-Erik, Rubin Mark A

Abstract excerpt

Although prostate cancer is a leading cause of cancer death, most men die with and not from their disease, underscoring the urgency to distinguish potentially lethal from indolent prostate cancer. We tested the prognostic value of a previously identified multigene signature of prostate cancer progression to predict cancer-specific death. The Orebro Watchful Waiting Cohort included 172 men with localized prostate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to In Situ Hybridization, Fluorescence

Share to Prostatic Neoplasms

Share to Serine Endopeptidases

Share to Severity of Illness Index

Share to Survival Rate

Share to Sweden

Source

Open in PubMed Open full text

Identifiers

PMID: 18583469
DOI: 10.1158/1055-9965.EPI-08-0044
PMCID: PMC2536630

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Testing a multigene signature of prostate cancer death in the Swedish Watchful Waiting Cohort.PMID 18583469Read ↗

Diagnosis, staging, and risk stratification in prostate cancer: Utilizing diagnostic tools to avoid unnecessary therapies and side effects.Semantic proximity Read ↗

Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes.Semantic proximity Read ↗

Genome-wide association study of prostate cancer-specific survival.Semantic proximity Read ↗

Defining aggressive prostate cancer using a 12-gene model.Semantic proximity Read ↗

Prostate cancer (PCa) risk variants and risk of fatal PCa in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.Semantic proximity Read ↗

Genome-wide association study of prostate cancer mortality.Semantic proximity Read ↗

Confirmation of genetic variants associated with lethal prostate cancer in a cohort of men from hereditary prostate cancer families.Semantic proximity Read ↗

Ability of a Genomic Classifier to Predict Metastasis and Prostate Cancer-specific Mortality after Radiation or Surgery based on Needle Biopsy Specimens.Semantic proximity Read ↗

Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate Cancer.Semantic proximity Read ↗

Identifying drug sensitivity of multifocal primary prostate cancerSemantic proximity Read ↗

Identification of Prognostic Biomarkers for Prostate CancerSemantic proximity Read ↗

Transcriptomic heterogeneity in multifocal prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.